Antithrombotic therapy after percutaneous revascularization in patients on chronic oral anticoagulation treatment

Author(s):  
Juan M. Ruiz-Nodar ◽  
José Luis Ferreiro
2021 ◽  
Vol 21 (1) ◽  
Author(s):  
Ana Cristina Cabellos-García ◽  
Antonio Martínez-Sabater ◽  
Miguel Ángel Díaz-Herrera ◽  
Vicente Gea-Caballero ◽  
Enrique Castro-Sánchez

Abstract Background Assessment health literacy in people with cardiovascular health problems would facilitate the development of appropriate health strategies for the care and reduction of complications associated with oral anticoagulation therapy. Aim: To evaluate the relationship between health literacy and health and treatment outcomes (concordance with oral anticoagulants, Normalized Ratio control and occurrence of complications) in patients with cardiovascular pathology. Methods Observational, analytic and cross-sectional study carried out on 252 patients with cardiovascular pathology (atrial fibrillation, flutter or valve prosthesis), aged 50–85 years, accessing primary care services in Valencia (Spain) in 2018–2019. Variables referring to anticoagulant treatment with vitamin K antagonists (years of treatment, adequate control, polypharmacy and occurrence of complications, among others) and health literacy (Health Literacy Questionnaire) were analysed. Results All dimensions of health literacy were significantly related to the level of education (p < 0.02), social class (p < 0.02), an adequate control of acenocoumarol (p < 0.001), frequentation of health services (p < 0.001), information by patients to health professionals about anticoagulant treatment (p < 0.03), emergency care visits (p < 0.001) and unscheduled hospital admissions (p < 0.001). Conclusion Health literacy has a relevant influence on the adequate self-management of anticoagulation treatment and the frequency of complications. The different dimensions that comprise health literacy play an important role, but the “social health support” dimension seems to be essential for such optimal self-management. Trial registration ACC-ACE-2016-01. Registration date: December 2015.


2018 ◽  
Vol 21 ◽  
pp. S115
Author(s):  
S. Mueller ◽  
A. Meinecke ◽  
S. Buchwald ◽  
L. Heideman ◽  
D. Eriksson ◽  
...  

2020 ◽  
Vol 120 (06) ◽  
pp. 894-898 ◽  
Author(s):  
Peter Brønnum Nielsen ◽  
Thure Filskov Overvad

AbstractStroke prevention is a key clinical concern in the management of patients with atrial fibrillation. Oral anticoagulation treatment reduces the risk of disabling stroke, but the treatment increases the risk of bleeding. For decades, the decision to initiate oral anticoagulation has been guided by clinical risk scoring systems such as the CHADS2 and CHA2DS2-VASc scores. In this narrative review, we focus on the recent discussion of the “Sc” (Sex Category) criterion in the CHA2DS2-VASc score. Epidemiological considerations when assessing stroke rates in cohorts are discussed, and the implications of different methodological approaches are outlined. Next, we review studies investigating the association of the “Sc” criterion on the stroke rates under various approaches. Lastly, we discuss potential consequences of implementing the recently suggested sex-less CHA2DS2-VA score, which leaves out female sex from stroke risk assessment in atrial fibrillation.


2017 ◽  
Vol 16 (1) ◽  
pp. 116-124 ◽  
Author(s):  
H. Maagdenberg ◽  
M. B. Bierings ◽  
C. H. van Ommen ◽  
F. J. M. van der Meer ◽  
I. M. Appel ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document